Stanley Hirsch, D.Phil., has been a member of the company’s Board of Directors since 2005, and has served as Chairman of the Board at Foamix since May, 2016. Dr. Hirsch has 30 years of experience in executive positions across the healthcare, diagnostic, and agricultural/biotech industries. He has extensive executive and board level experience in public and private companies listed on both U.S and U.K exchanges. Dr. Hirsch is currently Group CEO at FuturaGene Ltd., a leading agricultural biotechnology company, where he has held this position since 2007. Prior to this role, Dr. Hirsch was the CEO at CBD Technologies Ltd., the predecessor company to FuturaGene, from 1995 until 2007. Prior executive positions held by Dr. Hirsch include CEO at a diagnostics company GamidaGen, and General Manager at Portman Pharmaceuticals. Dr. Hirsch currently also serves as Chairman of the Board of Directors at OWC Pharmaceutical Research Corporation (OWCP), and as a Board Director and Member of the Scientific Advisory Board of Biological Industries, a privately held research products company focused on the stem cell industry. Dr. Hirsch holds a D. Phil in Cell Biology and Immunology from Oxford University, England.